NASDAQ:CLDX – Page 2

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Celldex Therapeutics Inc.’s recently made public that its SVP AND CFO Martin Samuel Bates unloaded Company’s shares for reported $0.61

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

In a filing, Celldex Therapeutics Inc. revealed its SVP AND CFO Martin Samuel Bates unloaded Company’s shares for reported $0.61

Analysts Viewpoint

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Tag: NASDAQ:CLDX